Traxoprodil
Alternative Names: CP-101,606; NectivLatest Information Update: 17 Apr 2012
At a glance
- Originator Pfizer
- Class Antiparkinsonians; Neuroprotectants
- Mechanism of Action NR2B N-Methyl-D-Aspartate antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued CNS trauma; Major depressive disorder; Parkinson's disease; Stroke
Most Recent Events
- 31 Dec 2010 Discontinued - Phase-II for Major depressive disorder in USA (IV)
- 31 Dec 2010 Discontinued - Phase-II for Parkinson's disease in USA (IV)
- 31 Dec 2010 Discontinued - Phase-II for Stroke in USA (IV)